[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.176.107. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 2,958
Citations 0
Clinical Trials Update
August 23/30, 2016

Trial Launched to Eradicate Ebola From Semen

JAMA. 2016;316(8):809. doi:10.1001/jama.2016.11464

The Partnership for Research on Ebola Virus in Liberia (PREVAIL), a US-Liberia joint clinical research partnership, recently announced the opening of PREVAIL IV, a trial for male Ebola survivors with persistent Ebola virus RNA in their semen (http://bit.ly/29OtRa9). The trial is sponsored by the National Institute of Allergy and Infectious Diseases in partnership with the Ministry of Health of Liberia and Gilead Sciences. The six-month randomized, double-blind study will enroll 60 to 120 male Ebola survivors whose semen tested positive for Ebola virus RNA.

First Page Preview View Large
First page PDF preview
First page PDF preview
×